---
title: "Molbio Diagnostics Ltd (1286089) — Share Price, Financials & Analysis"
symbol: "1286089"
company: "Molbio Diagnostics Ltd"
canonical: "https://tapetide.com/stocks/1286089"
isin: "INE869T01028"
nse_symbol: "MOLBIO"
bse_code: "544866"
sector: "Healthcare"
industry: "Healthcare Equipment & Supplies"
market_cap_cr: 18529.44
generated_at: "2026-09-13T18:46:52.055Z"
---

# Molbio Diagnostics Ltd (1286089)

Canonical page: https://tapetide.com/stocks/1286089

## Company

- **NSE Symbol:** MOLBIO
- **BSE Code:** 544866
- **ISIN:** INE869T01028
- **Sector:** Healthcare
- **Industry:** Healthcare Equipment & Supplies
- **Macro Sector:** Healthcare
- **Listed Since:** 2026-08-17
- **Face Value:** ₹1
- **F&O Eligible:** No

## About

Molbio Diagnostics is an innovative point-
of-care (POC) diagnostics company that develops affordable, rapid, and accurate diagnostic solutions for infectious and non-communicable diseases. Its flagship product, Truenat, is a portable, battery-powered PCR testing platform that delivers results within 
an hour. Designed for use in resource-limited settings, it enables quick and decentralised disease diagnosis at the point of care.
Through its wholly owned subsidiary, 
Bigtec Labs, Molbio has strong research 
and development capabilities focused on creating diagnostic platforms for point-of-
care (POC) testing. From product development to large-scale deployment, the company aims 
to improve access to reliable and affordable healthcare for everyone.
https://www.molbiodiagnostics.com/wp-content/uploads/2026/08/Molbio-Diagnostics-Limited-Red-Herring-Prospectus.pdf#page=215 #}

## Latest Price

- **Price:** ₹1438.2
- **Change:** -71.2 (-4.72%)
- **Open:** ₹1545
- **Day High:** ₹1686.8
- **Day Low:** ₹1391.7
- **Previous Close:** ₹1509.4
- **Volume:** 22057840
- **As Of:** 2026-09-11T10:28:08+00:00

## Key Fundamentals

Observed at 2026-09-11T04:35:18.340309Z.

- **Market Cap:** ₹18529.44 Cr
- **Classification:** Smallcap
- **P/E (reported):** 106
- **Book Value:** ₹118.84
- **Price to Book:** 12.7
- **Dividend Yield:** 0%
- **ROE:** 12.54%
- **ROCE:** 16.63%
- **Debt to Equity:** 0.03
- **Revenue (yearly):** ₹1455.2 Cr
- **Net Income:** ₹164.1 Cr
- **EBITDA:** ₹330.9 Cr
- **52-Week High:** ₹1509.4
- **52-Week Low:** ₹807
- **RSI (14):** 74.41

## Key Insights

### Strengths

- Company is almost debt free.
- Debtor days have improved from 108 to 63.3 days.
- Company's working capital requirements have reduced from 169 days to 114 days

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -82.45% | 426.54% | -50% |
| ebitda margin growth | -36.57% | -13.34% | -19.76% | -52.73% |
| net income growth | -44.99% | 18.4% | 111% | -19% |
| revenue growth | -27.22% | 41.57% | 59% | 1% |
| roce | -39.82% | -20.01% | 1.34% | 20.03% |
| roe | -44.97% | -12.49% | 12.32% | -58.56% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Jun 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- |
| Sales | 95 | 439 | 399 |
| Expenses | 105 | 332 | 308 |
| Operating Profit | -10 | 107 | 92 |
| OPM % | -10 | 24 | 23 |
| Other Income | 1 | 3 | 1 |
| Interest | 2 | 9 | 9 |
| Depreciation | 7 | 10 | 8 |
| Profit before tax | -17 | 91 | 76 |
| Tax % | -23 | 28 | 25 |
| Net Profit | -13 | 66 | 57 |
| EPS in Rs | -5.95 | 5.83 | 5.02 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Sales | 1271 | 776 | 327 | 756 | 971 | 1313 |
| Expenses | 676 | 457 | 286 | 552 | 746 | 1062 |
| Operating Profit | 595 | 319 | 40 | 204 | 226 | 252 |
| OPM % | 47 | 41 | 12 | 27 | 23 | 19 |
| Other Income | 1 | 5 | 8 | -21 | -2 | 5 |
| Interest | 35 | 25 | 6 | 8 | 9 | 23 |
| Depreciation | 12 | 42 | 19 | 24 | 26 | 36 |
| Profit before tax | 549 | 258 | 23 | 152 | 188 | 198 |
| Tax % | 25 | 27 | 32 | 27 | 26 | 27 |
| Net Profit | 410 | 187 | 16 | 111 | 140 | 145 |
| EPS in Rs | 2027.06 | 833.37 | 69 | 493.01 | 62 | 12.83 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 2 | 2 | 2 | 2 | 2 | — |
| Reserves | 333 | 681 | 737 | 848 | 988 | — |
| Borrowings | 257 | 105 | 57 | 70 | 26 | — |
| Other Liabilities | 215 | 85 | 123 | 157 | 291 | — |
| Total Liabilities | 806 | 874 | 920 | 1077 | 1307 | — |
| Fixed Assets | 55 | 182 | 189 | 209 | 215 | — |
| CWIP | 100 | 0 | 0 | 2 | 18 | — |
| Investments | 9 | 9 | 54 | 54 | 95 | — |
| Other Assets | 643 | 683 | 676 | 813 | 980 | — |
| Total Assets | 806 | 874 | 920 | 1077 | 1307 | — |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 344 | 98 | 68 | 38 | 249 | — |
| Cash from Investing Activity | -142 | -87 | -51 | -31 | -98 | — |
| Cash from Financing Activity | -192 | -20 | 31 | -24 | -17 | — |
| Net Cash Flow | 10 | -9 | 48 | -18 | 133 | — |
| Free Cash Flow | 212 | 35 | 55 | 24 | 206 | — |
| CFO/OP | 78 | 53 | 251 | 39 | 139 | — |

### Ratios

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 61 | 113 | 194 | 174 | 86 | — |
| Inventory Days | 261 | 402 | 885 | 393 | 395 | — |
| Days Payable | 124 | 64 | 201 | 129 | 226 | — |
| Cash Conversion Cycle | 198 | 450 | 877 | 438 | 254 | — |
| Working Capital Days | 75 | 206 | 479 | 239 | 155 | — |
| ROCE % | — | 41 | 4 | 22 | 21 | — |

## Shareholding Pattern

### Quarterly

| Category | Aug 2025 | Aug 2026 |
| --- | --- | --- |
| Promoters | 46.65% | 41.29% |
| FIIs | 0% | 1.51% |
| DIIs | 0% | 16.37% |
| Government | 0% | 0% |
| Public | 0% | 27.64% |
| Others | 53.35% | 13.19% |
| No. of Shareholders | 39 | 42 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Buy
- **Buy / Neutral / Sell:** 5 / 13 / 1

### Moving Averages — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 1199.33 | Buy |
| EMA (10) | 1252.83 | Buy |
| SMA (20) | 1161.1 | Buy |
| EMA (20) | 1161.1 | Buy |
| SMA (50) | — | Neutral |
| EMA (50) | — | Neutral |
| SMA (100) | — | Neutral |
| EMA (100) | — | Neutral |
| SMA (200) | — | Neutral |
| EMA (200) | — | Neutral |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 68.51 | Neutral |
| MACD (12,26,9) | — | Neutral |
| Stochastic (14,3,3) | 82.69 | Sell |
| ADX (14) | — | Neutral |
| Williams %R (14) | -38.15 | Neutral |
| ATR (14) | 114.63 | High Volatility |
| ROC (12) | 16.09 | Buy |
| Stoch RSI (14) | — | Neutral |
| UO (7,14,28) | — | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-09 | [Change Of Corporate Identification Number (CIN) Of The Company.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4204def2-8879-4865-b104-2b131d4ca67b.pdf) |
| 2026-09-07 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3f44849-7f19-41f9-b585-d4f5774e904a.pdf) |
| 2026-09-07 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b658bbb-16d0-4577-bcbb-dc4df36c64b1.pdf) |
| 2026-09-05 | [Board Meeting Outcome for Outcome Of Board Meeting.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f6b026a-517b-41ac-924f-b46c1e0e2219.pdf) |
| 2026-09-02 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50fb416a-a62c-498e-8bb8-1a6405770c29.pdf) |
| 2026-09-01 | [Board Meeting Intimation for To Consider And Approve The Financial Results For The Quarter Ended 30 June 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=21e81351-bff1-466e-8fc5-581c463d64aa.pdf) |
| 2026-08-27 | [Board Meeting Outcome for Outcome Of Board Meeting Held On August 27 2026 As Per Reg 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations).](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=276723cf-2cfc-4b2e-86a4-459b0f76002e.pdf) |
| 2026-08-20 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37bca122-1d9a-4ac8-bd95-7f594ead0758.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-09-08 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc927fc5-ef3e-46b1-bf23-b155d8162fe3.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-09-08 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc11e551-c48a-491e-96e4-f8bce73ffdec.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-09-05 | [Outcome Of Board Meeting Held On Saturday September 05 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0f41ff2b-3974-4532-b329-5794337b6ce8.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:46:52.055Z.